Conversion of adult endothelium to immunocompetent haematopoietic stem cells

Nature
Raphael LisShahin Rafii

Abstract

Developmental pathways that orchestrate the fleeting transition of endothelial cells into haematopoietic stem cells remain undefined. Here we demonstrate a tractable approach for fully reprogramming adult mouse endothelial cells to haematopoietic stem cells (rEC-HSCs) through transient expression of the transcription-factor-encoding genes Fosb, Gfi1, Runx1, and Spi1 (collectively denoted hereafter as FGRS) and vascular-niche-derived angiocrine factors. The induction phase (days 0-8) of conversion is initiated by expression of FGRS in mature endothelial cells, which results in endogenous Runx1 expression. During the specification phase (days 8-20), RUNX1+FGRS-transduced endothelial cells commit to a haematopoietic fate, yielding rEC-HSCs that no longer require FGRS expression. The vascular niche drives a robust self-renewal and expansion phase of rEC-HSCs (days 20-28). rEC-HSCs have a transcriptome and long-term self-renewal capacity similar to those of adult haematopoietic stem cells, and can be used for clonal engraftment and serial primary and secondary multi-lineage reconstitution, including antigen-dependent adaptive immune function. Inhibition of TGFβ and CXCR7 or activation of BMP and CXCR4 signalling enhanced generation ...Continue Reading

References

Jul 20, 1999·Journal of Immunological Methods·M M RodenF M Marincola
Mar 29, 2002·Nature Immunology·Stuart H Orkin, Leonard I Zon
Sep 6, 2005·Experimental Hematology·Thierry JaffredoMarella de Bruijn
Nov 28, 2008·Proceedings of the National Academy of Sciences of the United States of America·Marco SeandelShahin Rafii
Dec 2, 2008·Cell Stem Cell·Ann C ZoveinM Luisa Iruela-Arispe
Feb 16, 2010·Nature·Jean-Charles BoissetCatherine Robin
Mar 15, 2012·Blood·Karen K Hirschi
May 10, 2013·Nature Biotechnology·Christopher M SturgeonGordon Keller
Jun 19, 2013·Cell Stem Cell·Carlos-Filipe PereiraKateri Moore
Jan 17, 2014·Nature·Sean J Morrison, David T Scadden
Aug 8, 2014·Nature Medicine·Avital Mendelson, Paul S Frenette
Sep 2, 2014·Stem Cells·Julian PulecioJuan Carlos Izpisua Belmonte
Nov 25, 2014·Cell·Raquel Espín-PalazónDavid Traver
Dec 4, 2014·Cell Reports·Kiran BattaGeorges Lacaud
Jan 23, 2016·Nature·Shahin RafiiBi-Sen Ding
Feb 6, 2016·Cellular and Molecular Life Sciences : CMLS·Emily Gritz, Karen K Hirschi
Oct 28, 2016·Nature Cell Biology·Lara Wahlster, George Q Daley
Feb 14, 2017·Stem Cells Translational Medicine·Joshua P SasineJohn P Chute
Mar 17, 2017·Advances in Experimental Medicine and Biology·Amanda D YzaguirreNancy A Speck

❮ Previous
Next ❯

Citations

May 18, 2017·Nature·Carolina Guibentif, Berthold Göttgens
May 13, 2017·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Sandhya R PanchDavid F Stroncek
Feb 25, 2018·Nature Immunology·Gregoire Stik, Thomas Graf
Feb 23, 2018·Leukemia·Saloomeh MokhtariGraça Almeida-Porada
Jul 18, 2018·The Journal of Clinical Investigation·Xiaorong GuYogen Saunthararajah
Jan 6, 2018·Circulation Research·Ergin BeyretJuan Carlos Izpisua Belmonte
Aug 24, 2017·The Journal of Experimental Medicine·Julie R PerlinLeonard I Zon
Aug 10, 2018·Blood·Bradley W Blaser, Leonard I Zon
Sep 28, 2017·Nature·Elie Dolgin
Jan 25, 2018·Nature·Elisa Laurenti, Berthold Göttgens
May 3, 2019·BMC Bioinformatics·Arnaud BonnaffouxOlivier Gandrillon
May 16, 2019·Journal of Zhejiang University. Science. B·Su-Wei Gao, Feng Liu
Jun 24, 2017·Lab Animal·Dustin M Graham
Jul 4, 2019·Nature Biotechnology·Melissa A KinneyGeorge Q Daley
Jan 14, 2018·Science Immunology·Tobias WertheimerMarcel R M van den Brink
Nov 15, 2019·FEBS Letters·José Gabriel Barcia DuránShahin Rafii
Oct 7, 2017·Current Opinion in Hematology·Kandace GollompMortimer Poncz
Apr 15, 2020·The Journal of Experimental Medicine·Pradeep RamalingamJason M Butler
Oct 18, 2019·Annals of the New York Academy of Sciences·Michael G DanielKateri A Moore
Nov 17, 2019·Cellular and Molecular Life Sciences : CMLS·Nausicaa PoulletKarima Kissa
Dec 9, 2017·Expert Opinion on Biological Therapy·Massimo ConeseAnnalucia Carbone
May 8, 2018·International Journal of Hematology·Fumio Arai
Nov 16, 2018·Nature Protocols·José Gabriel Barcia DuránShahin Rafii
Mar 25, 2019·Biochemical Society Transactions·Katrin Ottersbach
Nov 7, 2019·Nature Cell Biology·Mehmet SaçmaMaria Carolina Florian
Jun 30, 2018·Nature Communications·Chloé S BaronCatherine Robin
Mar 19, 2019·Frontiers in Medicine·Mario A Torres-AcostaMarion E G Brunck
Feb 24, 2019·Cellular & Molecular Immunology·Haide ChenGuoji Guo
Aug 10, 2019·Nature Communications·Florian BonkhoferRoger Patient
Feb 13, 2020·F1000Research·Ana G Freire, Jason M Butler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.